EQS-News: Cheplapharm AG / Key word(s): PersonnelCaroline Jacquin appointed Managing Director of CHEPLAPHARM France SAS 03.04.2024 / 10:10 CET/CESTThe issuer is solely responsible for the content of this announcement.Greifswald / Levallois-Perret, 03. April 2024Caroline Jacquin will take over the management of CHEPL...
/PRNewswire/ -- The intrauterine contraceptive devices (IUD) market is estimated to grow by USD 965.49 million from 2023 to 2027 at a CAGR of 3.98% according...
NanoVibronix (NAOV) Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Independent Urology Company to Study the Potential for UroShield Distribution in Germany and other European MarketsELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Th...
NanoVibronix, Inc.: NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
EQS-Media / 21.09.2023 / 13:41 CET/CESTCHEPLAPHARM Arzneimittel GmbH (“CHEPLAPHARM” or the “Company”), a leading international platform for well-established branded medicines, took advantage of the currently favorable market conditions and successfully placed additional senior secured notes with a total volume of €3...